Insider · CIK 0001317664

Roberts Alan

Reports to the SEC for 3 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001317664

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-02-03	CORNERSTONE THERAPEUTICS INCOption to Purchase (Common Stock (Right to Buy)D Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−42.5K sh	$4.25	−$181K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCD Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−62.6K sh	$9.50	−$594K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCOption to Purchase (Common Stock (Right to Buy)D Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−12.5K sh	$3.76	−$47K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCD Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−18.4K sh	$9.50	−$175K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCOption to Purchase (Common Stock (Right to Buy)D Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−50K sh	$4.24	−$212K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCOption to Purchase (Common Stock (Right to Buy)D Disposition to Issuer	VP, Scientific Affairs	DDisposition to Issuer	−50K sh	$0.20	−$10K	0
2013-03-05	CORNERSTONE THERAPEUTICS INCA Award	VP, Scientific Affairs	AAward	+18.4K sh	—	—	80,947
2012-05-25	CORNERSTONE THERAPEUTICS INCF Tax Payment	VP, Scientific Affairs	FTax Payment	−5,678 sh	$5.04	−$28.6K	62,572
2012-02-29	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)A Award	VP, Scientific Affairs	AAward	+12.5K sh	—	—	12,500
2011-05-26	CORNERSTONE THERAPEUTICS INCS Sale	VP, Scientific Affairs	SSale	−5,850 sh	$7.60	−$44.5K	68,250
2011-03-02	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)A Award	VP, Scientific Affairs	AAward	+42.5K sh	—	—	42,500
2010-03-03	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)A Award	VP, Scientific Affairs	AAward	+50K sh	—	—	50,000
2007-07-02	AURIGA LABORATORIES, INC.S Sale	Chief Scientific Officer	SSale	−4,000 sh	$1.06	−$4,240	100,000
2007-07-02	AURIGA LABORATORIES, INC.S Sale	Chief Scientific Officer	SSale	−1,000 sh	$1.10	−$1,100	104,000
2007-06-01	AURIGA LABORATORIES, INC.S Sale	Chief Scientific Officer	SSale	−1,000 sh	$1.35	−$1,350	109,000
2007-06-01	AURIGA LABORATORIES, INC.S Sale	Chief Scientific Officer	SSale	−1,500 sh	$1.40	−$2,100	107,500
2007-06-01	AURIGA LABORATORIES, INC.S Sale	Chief Scientific Officer	SSale	−2,500 sh	$1.45	−$3,625	105,000

Recent filings

Accepted (ET)
Feb 44
CORNERSTONE THERAPEUTICS INC0001209191-14-006768
SEC(opens sec.gov)
Mar 74
Roberts Alan0001209191-13-014911
SEC(opens sec.gov)
May 304
Roberts Alan0001209191-12-031117
SEC(opens sec.gov)
Apr 34
Roberts Alan0001209191-12-021332
SEC(opens sec.gov)
May 314
Roberts Alan0001209191-11-031779
SEC(opens sec.gov)
Mar 44
Roberts Alan0001209191-11-015386
SEC(opens sec.gov)
Mar 94
Roberts Alan0001209191-10-015594
SEC(opens sec.gov)
Jul 24
AURIGA LABORATORIES, INC.0000914062-07-000322
SEC(opens sec.gov)
Jun 54
AURIGA LABORATORIES, INC.0000914062-07-000286
SEC(opens sec.gov)

Companies

Address

C/O CORNERSTONE THERAPEUTICS 1255 CRESCENT GREEN DRIVE, SUITE 250

CARY, NC, 27518